Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 68,019 | 70,095 | 67,899 | 62,669 | 67,653 |
| Cost of Goods | 6,236 | 6,797 | 6,566 | 6,030 | 6,412 |
| Gross Profit | 61,783 | 63,298 | 61,333 | 56,639 | 61,241 |
| Operating Expenses | 53,383 | 53,276 | 49,530 | 46,328 | 51,202 |
| Operating Income | 8,636 | 10,819 | 12,369 | 10,341 | 10,451 |
| Other Income | -26 | -97 | 235 | 87 | 473 |
| Pre-tax Income | 8,610 | 10,722 | 12,604 | 10,428 | 10,924 |
| Income Tax | 1,532 | 2,951 | 2,951 | 1,778 | 2,734 |
| Net Income Continuous | 7,078 | 7,771 | 9,653 | 8,650 | 8,190 |
| Net Income | $7,078 | $7,771 | $9,653 | $8,650 | $8,190 |
| EPS Basic Total Ops | 0.13 | 0.14 | 0.17 | 0.16 | 0.15 |
| EPS Basic Continuous Ops | 0.13 | 0.14 | 0.17 | 0.16 | 0.15 |
| EPS Diluted Total Ops | 0.12 | 0.14 | 0.17 | 0.15 | 0.14 |
| EPS Diluted Continuous Ops | 0.12 | 0.14 | 0.17 | 0.15 | 0.15 |
| EBITDA(a) | $9,540 | $11,962 | $13,607 | $11,546 | $11,518 |